Preliminary experiments show conolidine could inhibit precise ion channels, decreasing neuronal excitability and restricting soreness indicators. This system is especially suitable in neuropathic agony, in which abnormal signaling will cause persistent soreness. In addition, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to soreness perception. Compu... https://charlesf283yof8.blogdun.com/profile